Science funding in PsA is an unmet need

Psoriasis Arthritis (PsA) is an inflammatory disease associated with psoriatic skin disease, which affects 1 upto 3 percent of the population in Europe. PsA is one of the most severe inflammatory joint diseases. Although substantial progress has been achieved in understanding the pathogenesis, outcome and treatment of PsA, there is still an unmet need to better characterize PsA. The PARTNER Fellowship Program aims to address unsolved questions in the field of PsA.

Georg Schett, MD.
Full Professor and Head of Department of Internal Medicine 3, University Hospital Erlangen, Germany